ALPS Medical Breakthroughs ETF
SBIO
46 hedge funds and large institutions have $45M invested in ALPS Medical Breakthroughs ETF in 2020 Q1 according to their latest regulatory filings, with 10 funds opening new positions, 9 increasing their positions, 16 reducing their positions, and 13 closing their positions.
222% more call options, than puts
Call options by funds: $832K | Put options by funds: $258K
4.72% more ownership
Funds ownership: 24.65% → 29.38% (+4.7%)
10% less funds holding
Funds holding: 51 → 46 (-5)
19% less capital invested
Capital invested by funds: $55.2M → $45M (-$10.2M)
23% less first-time investments, than exits
New positions opened: 10 | Existing positions closed: 13
44% less repeat investments, than reductions
Existing positions increased: 9 | Existing positions reduced: 16
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$3.64M |
| 2 |
Morgan Stanley
New York
|
+$1.75M |
| 3 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
+$1.4M |
| 4 |
Wells Fargo
San Francisco,
California
|
+$1.14M |
| 5 |
BCM
Barometer Capital Management
Toronto,
Ontario, Canada
|
+$727K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CCP
Cardan Capital Partners
Denver,
Colorado
|
-$1.01M |
| 2 |
UBS Group
Zurich,
Switzerland
|
-$720K |
| 3 |
Citadel Advisors
Miami,
Florida
|
-$712K |
| 4 |
ASN
Advisory Services Network
Atlanta,
Georgia
|
-$453K |
| 5 |
CWA
Capital Wealth Alliance
Scottsdale,
Arizona
|
-$353K |
SBIO Hedge Fund Activity: Q1 2020 in Review
46 of the 4,547 institutional investors tracked by Wall St. Rank reported a position in ALPS Medical Breakthroughs ETF (SBIO) for Q1 2020, worth a combined $45M — down 19% from $55.2M a quarter earlier.
Sellers outnumbered buyers: 13 funds closed out of SBIO and 10 opened new positions — a net loss of 3 holders — while 16 trimmed existing stakes and 9 added.
The largest buyer was Susquehanna International Group, opening a new position worth an estimated $3.64M. The largest seller was Cardan Capital Partners, cutting an estimated $1.01M.
- 46 institutional investors held ALPS Medical Breakthroughs ETF (SBIO) as of Q1 2020, down from 51 in Q4 2019.
- Funds reported $45M of ALPS Medical Breakthroughs ETF stock for Q1 2020, down 19% quarter-over-quarter.
- 10 funds opened new ALPS Medical Breakthroughs ETF positions in Q1 2020 and 13 closed out, a net change of -3 holders.
- The largest ALPS Medical Breakthroughs ETF buyer in Q1 2020 was Susquehanna International Group, an estimated $3.64M added.
- The largest ALPS Medical Breakthroughs ETF seller in Q1 2020 was Cardan Capital Partners, an estimated $1.01M sold.
Based on aggregated 13F filings for Q1 2020.